We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson Sues FDA Over Actos Generic Exclusivity as Competitors Launch
Watson Sues FDA Over Actos Generic Exclusivity as Competitors Launch
August 28, 2012
Watson Pharmaceuticals is suing the FDA after it failed to grant the company shared exclusivity on a generic of Type 2 diabetes drug Actos.